1. From the Division of Pediatric Oncology, Dana-Farber Cancer Institute, the Department of Pediatrics, Harvard Medical School, Boston, MA; and the Department of Molecular and Medical Genetics, the Department of Pediatrics, Oregon Health Sciences University, Portland.